Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Jazz Pharmaceuticals
Jazz Pharmaceuticals
BeiGene
Taproot Health
Istari Oncology, Inc.
Quadriga Biosciences, Inc.
Biogen
Tocagen Inc.
Novartis
Exelixis
INSYS Therapeutics Inc
Novartis
Daiichi Sankyo
TransMolecular
Siemens Molecular Imaging
MediGene